Yiming Zhang

机构：Ministry of Education of the People's Republic of China, Shandong University of Traditional Chinese Medicine, Jinan University, Dalian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Indigenous Peoples' Health, First Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Zhengzhou University, Northeast Forestry University · ORCID：0000-0001-5959-0963

发表论文 61 篇 · 总被引 851 次 · h-index 16

代表论文

• Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC (2024 · Hepatology · 被引 65)
• Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers (2023 · Pharmaceutics · 被引 40)
• An Intelligent Vascular Disrupting Dendritic Nanodevice Incorporating Copper Sulfide Nanoparticles for Immune Modulation‐Mediated Combination Tumor Therapy (2023 · Small · 被引 34)
• Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma (2025 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• Membrane-bound supramolecular nanofiber network stimulates transient receptor potential channels for calcium overload cancer therapy (2023 · Nano Today · 被引 21)
• RETRACTED: LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway (2023 · Cancers · 被引 21)